Form ARS Candel Therapeutics, For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Candel Therapeutics names Mark Sims as chief commercial officer
- Notice of Annual and Special Meeting of Shareholders
- Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
